Abstract
The presence of resistant pneumococcal organisms has become a major problem in the world today. These organisms are responsible for changing the methodology required for susceptibility testing and for the newly proposed guidelines for resistance. These newly proposed MICs are still under consideration because of the limited data used for their establishment. The treatment of resistant pneumococcal infections outside of the central nervous system is not yet well standardized. Central nervous system infections should be approached with care and a knowledge of current recommendations for their therapy. We expect changes in the recommendations for therapy over the coming years until a standardized approach can be established.
Original language | English (US) |
---|---|
Pages (from-to) | 233-237 |
Number of pages | 5 |
Journal | Infection |
Volume | 22 |
Issue number | 4 |
DOIs | |
State | Published - Jul 1 1994 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases